These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 24754737

  • 1. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
    Maurin H, Lechat B, Borghgraef P, Devijver H, Jaworski T, Van Leuven F.
    Eur J Neurosci; 2014 Jul; 40(2):2442-53. PubMed ID: 24754737
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathy.
    Crespo-Biel N, Theunis C, Borghgraef P, Lechat B, Devijver H, Maurin H, Van Leuven F.
    Neurobiol Dis; 2014 Jul; 67():119-32. PubMed ID: 24704314
    [Abstract] [Full Text] [Related]

  • 3. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C, Borghgraef P, Matarazzo V, Gielis L, Lajard AM, Voituron N, Gestreau C, Dutschmann M, Van Leuven F, Hilaire G.
    Respir Physiol Neurobiol; 2011 Sep 15; 178(2):290-303. PubMed ID: 21763469
    [Abstract] [Full Text] [Related]

  • 4. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
    Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH.
    Am J Pathol; 2003 Sep 15; 163(3):1057-67. PubMed ID: 12937146
    [Abstract] [Full Text] [Related]

  • 5. Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice.
    Köhler C, Dinekov M, Götz J.
    Neurobiol Aging; 2013 May 15; 34(5):1369-79. PubMed ID: 23294633
    [Abstract] [Full Text] [Related]

  • 6. Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
    Maurin H, Chong SA, Kraev I, Davies H, Kremer A, Seymour CM, Lechat B, Jaworski T, Borghgraef P, Devijver H, Callewaert G, Stewart MG, Van Leuven F.
    PLoS One; 2014 May 15; 9(2):e87605. PubMed ID: 24498342
    [Abstract] [Full Text] [Related]

  • 7. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
    Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F.
    Am J Pathol; 2008 Mar 15; 172(3):786-98. PubMed ID: 18258852
    [Abstract] [Full Text] [Related]

  • 8. Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice.
    Xu J, Sato S, Okuyama S, Swan RJ, Jacobsen MT, Strunk E, Ikezu T.
    FASEB J; 2010 Aug 15; 24(8):2904-15. PubMed ID: 20354135
    [Abstract] [Full Text] [Related]

  • 9. Tau phosphorylation in hippocampus results in toxic gain-of-function.
    Avila J, Gómez de Barreda E, Engel T, Lucas JJ, Hernández F.
    Biochem Soc Trans; 2010 Aug 15; 38(4):977-80. PubMed ID: 20658988
    [Abstract] [Full Text] [Related]

  • 10. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T, Yu JT, Zhu XC, Zhang QQ, Cao L, Wang HF, Tan MS, Gao Q, Qin H, Zhang YD, Tan L.
    Neuropharmacology; 2014 Oct 15; 85():121-30. PubMed ID: 24880087
    [Abstract] [Full Text] [Related]

  • 11. Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway.
    Chen KL, Yuan RY, Hu CJ, Hsu CY.
    Neurobiol Dis; 2010 Nov 15; 40(2):378-85. PubMed ID: 20615469
    [Abstract] [Full Text] [Related]

  • 12. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J, Levy M, Dickson DW, Potter H.
    Brain; 2006 Nov 15; 129(Pt 11):3020-34. PubMed ID: 16987932
    [Abstract] [Full Text] [Related]

  • 13. A 4R tauopathy develops without amyloid deposits in aged cat brains.
    Poncelet L, Ando K, Vergara C, Mansour S, Suain V, Yilmaz Z, Reygel A, Gilissen E, Brion JP, Leroy K.
    Neurobiol Aging; 2019 Sep 15; 81():200-212. PubMed ID: 31306814
    [Abstract] [Full Text] [Related]

  • 14. Interneuronal transfer of human tau between Lamprey central neurons in situ.
    Kim W, Lee S, Jung C, Ahmed A, Lee G, Hall GF.
    J Alzheimers Dis; 2010 Sep 15; 19(2):647-64. PubMed ID: 20110609
    [Abstract] [Full Text] [Related]

  • 15. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
    Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, Van Leuven F.
    J Biol Chem; 2005 Feb 04; 280(5):3963-73. PubMed ID: 15509565
    [Abstract] [Full Text] [Related]

  • 16. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
    Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A.
    Eur J Neurosci; 2011 May 04; 33(9):1598-610. PubMed ID: 21453448
    [Abstract] [Full Text] [Related]

  • 17. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.
    Buccarello L, Grignaschi G, Castaldo AM, Di Giancamillo A, Domeneghini C, Melcangi RC, Borsello T.
    J Alzheimers Dis; 2017 May 04; 56(4):1279-1292. PubMed ID: 28157099
    [Abstract] [Full Text] [Related]

  • 18. A mouse model to study tau pathology related with tau phosphorylation and assembly.
    Engel T, Lucas JJ, Hernández F, Avila J.
    J Neurol Sci; 2007 Jun 15; 257(1-2):250-4. PubMed ID: 17362999
    [Abstract] [Full Text] [Related]

  • 19. Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.
    Rockenstein E, Ubhi K, Trejo M, Mante M, Patrick C, Adame A, Novak P, Jech M, Doppler E, Moessler H, Masliah E.
    BMC Neurosci; 2014 Jul 21; 15():90. PubMed ID: 25047000
    [Abstract] [Full Text] [Related]

  • 20. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
    Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, de Vos K, Krugers H, Tomiyama T, Mori H, Joels M, van Leuven F, Lucassen PJ.
    J Neurosci; 2006 Mar 29; 26(13):3514-23. PubMed ID: 16571759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.